|
Market Closed -
NSE India S.E.
12:05:07 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1,394.50 INR | +1.32% |
|
+2.09% | -7.73% |
| 09-03 | India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar | RE |
| 08-25 | Cipla's Pithampur, India Unit Gets 7 Observations From US FDA | MT |
Company Valuation: Cipla Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 821,377 | 726,839 | 1,208,588 | 1,164,745 | 988,887 | 1,126,547 | - | - |
| Change | - | -11.51% | 66.28% | -3.63% | -15.1% | 13.92% | - | - |
| Enterprise Value (EV) 1 | 810,334 | 716,397 | 1,154,239 | 1,084,736 | 901,599 | 1,020,473 | 995,103 | 978,711 |
| Change | - | -11.59% | 61.12% | -6.02% | -16.88% | 13.18% | -2.49% | -1.65% |
| P/E | 32.7x | 26x | 29.3x | 22.1x | 25.5x | 27.1x | 21.9x | 19.2x |
| PBR | 3.94x | 3.11x | 4.53x | 3.73x | 2.87x | 3x | 2.72x | 2.46x |
| PEG | - | 2.3x | 0.6x | 0.8x | -1x | 3.86x | 0.9x | 1.4x |
| Capitalization / Revenue | 3.77x | 3.19x | 4.69x | 4.23x | 3.51x | 3.64x | 3.24x | 2.97x |
| EV / Revenue | 3.72x | 3.15x | 4.48x | 3.94x | 3.2x | 3.29x | 2.86x | 2.58x |
| EV / EBITDA | 17.8x | 14.3x | 18.3x | 15.2x | 15.3x | 17.1x | 13.5x | 11.8x |
| EV / EBIT | 23.1x | 18.6x | 22x | 18x | 19.3x | 21.9x | 16.7x | 14.3x |
| EV / FCF | 29.1x | 29.9x | 38x | 28.2x | 38.5x | 36x | 27.6x | 22.9x |
| FCF Yield | 3.43% | 3.35% | 2.63% | 3.54% | 2.6% | 2.78% | 3.62% | 4.37% |
| Dividend per Share 2 | 5 | 8.5 | 13 | 13 | 13 | 12.99 | 14.73 | 14.61 |
| Rate of return | 0.49% | 0.94% | 0.87% | 0.9% | 1.06% | 0.93% | 1.06% | 1.05% |
| EPS 2 | 31.17 | 34.69 | 51.01 | 65.24 | 48 | 51.37 | 63.73 | 72.44 |
| Distribution rate | 16% | 24.5% | 25.5% | 19.9% | 27.1% | 25.3% | 23.1% | 20.2% |
| Net sales 1 | 217,633 | 227,531 | 257,741 | 275,476 | 281,626 | 309,885 | 347,371 | 379,448 |
| EBITDA 1 | 45,528 | 50,270 | 62,910 | 71,279 | 58,829 | 59,815 | 73,616 | 82,917 |
| EBIT 1 | 35,008 | 38,549 | 52,400 | 60,210 | 46,719 | 46,616 | 59,588 | 68,666 |
| Net income 1 | 25,168 | 28,019 | 41,216 | 52,725 | 38,792 | 41,355 | 51,424 | 58,494 |
| Net Debt 1 | -11,043 | -10,443 | -54,350 | -80,010 | -87,289 | -106,073 | -131,444 | -147,836 |
| Reference price 2 | 1,018.05 | 900.50 | 1,496.95 | 1,442.20 | 1,224.20 | 1,394.50 | 1,394.50 | 1,394.50 |
| Nbr of stocks (in thousands) | 806,814 | 807,151 | 807,367 | 807,617 | 807,783 | 807,850 | - | - |
| Announcement Date | 10/05/22 | 12/05/23 | 10/05/24 | 13/05/25 | 13/05/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 27.15x | 3.29x | 17.06x | 0.93% | 11.74B | |
| 33.9x | 6.35x | 22.04x | 0.93% | 45.94B | |
| 15.9x | 1.97x | 8.74x | 1.7% | 37.22B | |
| 27.81x | 3.97x | 16.44x | 0.58% | 12.06B | |
| 18.58x | 3.37x | 11.75x | 3.79% | 9.03B | |
| 9.44x | 2.18x | 5.65x | 4.7% | 7.36B | |
| 29.77x | 3.9x | 18.12x | 0.16% | 7.2B | |
| 15.18x | 2.01x | 6.67x | 3.28% | 7.15B | |
| 35.54x | 6.93x | 25.35x | 0.98% | 4.64B | |
| Average | 23.70x | 3.77x | 14.65x | 1.89% | 15.82B | |
| Weighted average by Cap. | 24.79x | 4.02x | 15.31x | 1.56% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CIPLA Stock
- Valuation Cipla Limited
Select your edition
All financial news and data tailored to specific country editions
